期刊： CASE REPORTS IN ONCOLOGY, 2021; 14 (1)
Laryngeal squamous cell carcinoma (LSCC) is the most common malignant head and neck cancer, with a 40% recurrence rate in the first 3 years after radi......
期刊： CASE REPORTS IN ONCOLOGY, 2021; 14 (2)
Abdominal metastasis is relatively rare in dedifferentiated liposarcoma of the shoulder and back. Surgery is the best treatment option, whether it is ......
期刊： CASE REPORTS IN ONCOLOGY, 2021; 14 (1)
We report an unusual presentation of primary hepatic neuroendocrine tumor which was initially misdiagnosed as intrahepatic cholangiocarcinoma. The dia......
期刊： CASE REPORTS IN ONCOLOGY, 2021; 14 (1)
The coexistence of lung cancer and pulmonary tuberculosis (TB) is rare, and the clinical and radiological features are always similar between lung can......
期刊： CASE REPORTS IN ONCOLOGY, 2021; 14 (2)
Pregnancy with choriocarcinoma is a rare tumor. It is rare for neonates to survive the third trimester. This article reports the clinical data of a li......
期刊： CASE REPORTS IN ONCOLOGY, 2022; 15 (1)
A family with multiple members diagnosed with prostate cancer was identified, and genetic variants were analyzed. Three brothers were diagnosed with p......
期刊： CASE REPORTS IN ONCOLOGY, 2022; 15 (1)
Ewing sarcoma and primitive neuroectodermal tumors (ES/PNETs) are rare tumors that belong to a family of round-cell neuroectodermally derived tumors, ......
期刊： CASE REPORTS IN ONCOLOGY, 2022; 15 (1)
Viral reactivation or infections are common complications after allogeneic hematopoietic stem cell transplantation, especially in haploidentical trans......
期刊： CASE REPORTS IN ONCOLOGY, 2022; 15 (2)
The adrenal gland is a frequent site for metastasis, and the majority of the metastatic lesions of the adrenal gland normally originate from lung canc......
期刊： CASE REPORTS IN ONCOLOGY, 2022; 15 (3)
Liver metastasis commonly occurs; however, the luminal-type liver metastasis rarely develops at the early stage of breast cancer, posing key challenge......
期刊： CASE REPORTS IN ONCOLOGY, 2022; 15 (2)
ROS1 comprises a small molecular subset of NSCLC, and several fusion partners have been discovered. Concomitant mutations of EGFR and ROS1 in NSCLC ha......
